Dr. Brian Kavanagh graduated summa cum laude with honors in biomedical engineering from the Tulane University School of Engineering and then remained at Tulane to receive his MD and MPH degrees from the School of Medicine and School of Public Health. He completed an internship at the Charity Hospital of Louisiana before entering a radiation oncology residency at Duke University, where he was an American Cancer Society Clinical Oncology Fellow. His first faculty appointment was at the Medical College of Virginia, and later he moved to the University of Colorado, where he is now Professor and Chair of Radiation Oncology. During his career his research interests have encompassed laboratory and translational studies of how to enhance the effectiveness of radiotherapy by modulation tumor hypoxia and inhibition of macrophage activation, and he has also focused on Stereotactic Radiosurgery (SRS) for brain tumors and Stereotactic Body Radiation Therapy (SBRT) for extracranial tumors. His recent publications have addressed SRS and SBRT as well as “big data” studies of selected cancer population databases. He is involved in Health Policy decision making at the national level, serving on a Medicare Advisory Panel and also as President of the American Society for Radiation Oncology (ASTRO).